DXBDIMERIX LIMITED
Dimerix receives input from FDA on ACTION3 trial endpoints
- Date and time
- Announcement type
- Company Update
Show detailsHide details
- Category
- Other
- Report codes
- 11001
- Sector
- Health Care
- Industry group
- Pharmaceuticals, Biotechnology & Life Sciences
Recent DXB announcements
- Dimerix Receives US$10M Upfront Payment from Everest
- Dimerix Assumes Sponsorship of US IND for New Asset DMX-652
- Dimerix Presents at Bioshares Summit 2026
- Dimerix Quarterly Activities Report and Appendix 4C
- Dimerix to Present at TechKnow Invest Conference 2026
- US Patent Granted for Dimerix New Asset DMX-652